data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
SPY
––%
QQQ
––%
BTC/USD
––%
DIA
––%
GLD
––%
TLT
––%
Lipocine
(NASDAQ:LPCN)
$0.4566
At close: Dec 1(Delayed 15-Minutes)
Get Real Time Here
$0.4498
-0.0068[-1.49%]
PreMarket: 8:53AM EDT
Day Range- - -52 Wk Range0.36 - 1.89Open / Close- / -Float / Outstanding86.2M / 88.5M
Vol / Avg.- / 195.4KMkt Cap40.4MP/E11.4250d Avg. Price0.44
Div / Yield-Payout Ratio-Total Float86.2MEPS-0.03

Lipocine Stock (NASDAQ:LPCN), Quotes and News Summary

Lipocine Stock (NASDAQ: LPCN) stock price, news, charts, stock research, profile.

Day Range- - -52 Wk Range0.36 - 1.89Open / Close- / -Float / Outstanding86.2M / 88.5M
Vol / Avg.- / 195.4KMkt Cap40.4MP/E11.4250d Avg. Price0.44
Div / Yield-Payout Ratio-Total Float86.2MEPS-0.03
Vandana Singh - Sep 26, 2022, 11:39AM
Ragothaman Srinivasan - Jul 11, 2022, 10:21AM
Zacks Small Cap Research - May 20, 2022, 11:21AM
Lisa Levin - May 17, 2022, 8:10AM
Vandana Singh - May 12, 2022, 10:55AM
Zacks Small Cap Research - May 10, 2022, 3:31PM
Vandana Singh - Mar 29, 2022, 11:43AM
PRNewswire - Nov 9, 2022, 8:00AM
PRNewswire - Nov 3, 2022, 8:00AM
PRNewswire - Oct 11, 2022, 8:00AM
PRNewswire - Sep 27, 2022, 1:21PM
PRNewswire - Sep 26, 2022, 8:00AM
PRNewswire - Sep 22, 2022, 4:10PM
PRNewswire - Sep 15, 2022, 8:00AM
PRNewswire - Aug 8, 2022, 8:00AM
PRNewswire - Jul 11, 2022, 8:00AM
PRNewswire - Jun 14, 2022, 8:00AM
PRNewswire - Jun 6, 2022, 4:00PM
PRNewswire - May 12, 2022, 8:00AM
PRNewswire - May 9, 2022, 8:00AM
PRNewswire - Apr 11, 2022, 8:00AM
PRNewswire - Mar 29, 2022, 7:05AM
PRNewswire - Mar 9, 2022, 8:00AM
PRNewswire - Mar 1, 2022, 8:00AM
PRNewswire - Feb 3, 2022, 8:00AM
PRNewswire - Jan 27, 2022, 8:00AM
PRNewswire - Jan 5, 2022, 8:00AM
PRNewswire - Dec 22, 2021, 8:00AM
InvestorsObserver - Oct 6, 2022, 12:57PM
Seeking Alpha - Sep 26, 2022, 9:29AM
InvestorsObserver - Jul 11, 2022, 12:20PM
InvestorsObserver - Apr 25, 2022, 12:11PM
InvestorsObserver - Apr 20, 2022, 1:40PM
InvestorsObserver - Apr 18, 2022, 1:23PM
InvestorsObserver - Apr 4, 2022, 7:48AM
StockNews - Mar 31, 2022, 6:29AM
InvestorsObserver - Mar 30, 2022, 8:14AM
InvestorsObserver - Mar 29, 2022, 2:21PM
Seeking Alpha - Mar 29, 2022, 8:42AM
Seeking Alpha - Mar 29, 2022, 8:04AM
InvestorsObserver - Mar 29, 2022, 7:48AM
InvestorsObserver - Mar 28, 2022, 8:55AM
InvestorsObserver - Mar 24, 2022, 2:58PM
InvestorsObserver - Mar 22, 2022, 10:46AM
InvestorsObserver - Mar 8, 2022, 12:34PM
InvestorsObserver - Mar 3, 2022, 2:45PM
InvestorsObserver - Feb 28, 2022, 9:57AM
InvestorsObserver - Feb 9, 2022, 3:09PM
Seeking Alpha - Feb 3, 2022, 9:34AM
InvestorsObserver - Jan 26, 2022, 11:39AM
InvestorsObserver - Jan 5, 2022, 12:07PM
InvestorsObserver - Jan 4, 2022, 6:42AM
InvestorsObserver - Jan 3, 2022, 9:34AM
InvestorsObserver - Dec 30, 2021, 10:53AM
Seeking Alpha - Dec 22, 2021, 9:05AM
Sector: Health Care.Industry: Pharmaceuticals
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO, is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107.
Read More

Earnings

see more
Q3 2022Est.ActualSurprise
EPS-0.030-0.030 0.0000
REV700.000K0-700.000K
Q2 2022Est.ActualSurprise
EPS-0.040-0.040 0.0000
REV260.000K500.000K240.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Lipocine (LPCN) stock?

A

You can purchase shares of Lipocine (NASDAQ: LPCN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Lipocine's (LPCN) competitors?

Q

What is the target price for Lipocine (LPCN) stock?

A

The latest price target for Lipocine (NASDAQ: LPCN) was reported by HC Wainwright & Co. on Thursday, August 26, 2021. The analyst firm set a price target for 3.50 expecting LPCN to rise to within 12 months (a possible 666.54% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Lipocine (LPCN)?

A

The stock price for Lipocine (NASDAQ: LPCN) is $0.4566 last updated December 1, 2022, 9:00 PM UTC.

Q

Does Lipocine (LPCN) pay a dividend?

A

There are no upcoming dividends for Lipocine.

Q

When is Lipocine (NASDAQ:LPCN) reporting earnings?

A

Lipocine’s Q3 earnings are confirmed for Wednesday, November 9, 2022.

Q

Is Lipocine (LPCN) going to split?

A

There is no upcoming split for Lipocine.

Q

What sector and industry does Lipocine (LPCN) operate in?

A

Lipocine is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.